CRISPR-focused Excision BioTherapeutics Strengthens Board of Directors Appointing Veteran Pharmaceutical Executive Bill Carson, M.D.

    NEXT STORY
    RAPT Therapeutics and Hanmi Pharmaceutical Announce Collaboration to Develop and Commercialize FLX475 in Asia
    PREV STORY
    River Oaks Treatment Center Now Offering Addiction Track For First Responders
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    UroGen Pharma Reports Second Quarter 2017 Financial Results and Recent Corporate Developments

    Completed Initial Public Offering Raising $66.9 Million in Gross Proceeds Continuing Enrollment of Patients ...

    author_avatar
    NASDAQ Market News

    Akers Biosciences and Premas Biotech Announce Successful Completion of Vaccine Prototype & Obtained First Images of VLP

    author_avatar
    NASDAQ Market News

    Peregrine Pharmaceuticals Announces Appointment of Roger J. Lias, Ph.D. as President of Avid Bioservices

    TUSTIN, Calif., Sept. 11, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a ...

    author_avatar
    NASDAQ Market News